Analgesics Global Strategic Business Report 2024-2030: Market to Reach $72.8 Billion - US and Europe Represent the Largest Regions, Asia-Pacific to Witness fastest Growth - ResearchAndMarkets.com

The "Analgesics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for Analgesics was valued at US$53.5 Billion in 2024 and is projected to reach US$72.8 Billion by 2030, growing at a CAGR of 5.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The use of analgesics has evolved significantly over the years, driven by advances in medical research and an increasing understanding of pain mechanisms. New formulations and delivery methods, such as extended-release tablets and transdermal patches, have improved the efficacy and convenience of pain management. Additionally, the development of combination drugs that incorporate multiple analgesics into a single dose has enhanced pain relief outcomes by targeting different pain pathways simultaneously.

However, the widespread use of analgesics, particularly opioids, has led to significant public health challenges, including the opioid crisis, characterized by high rates of addiction and overdose. This has prompted a shift towards finding safer, non-addictive pain relief options, such as the development of new NSAIDs with fewer gastrointestinal side effects and increased research into non-pharmacological therapies.

The growth in the analgesics market is driven by several factors. Advancements in drug delivery systems have made analgesics more effective and user-friendly, with innovations like patient-controlled analgesia pumps and wearable drug delivery devices gaining popularity. The rising prevalence of chronic diseases such as arthritis and cancer, which often require long-term pain management, has also fueled demand for analgesics. Additionally, an aging global population is contributing to increased consumption of these medications, as older adults are more likely to experience chronic pain conditions. Consumer behavior trends show a growing preference for over-the-counter analgesics for quick and accessible pain relief, further boosting market growth.

Moreover, increased healthcare spending and greater access to medical care in developing regions are expanding the market's reach. Pharmaceutical companies are also investing heavily in research and development to create new analgesics with better safety profiles and effectiveness, responding to the growing demand for safer alternatives to traditional painkillers. These factors collectively underscore the dynamic and expanding nature of the analgesics market.

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Bristol-Myers Squibb Company, Bayer AG, Biological E. Ltd., Anabolic Laboratories LLC, BioDelivery Sciences International, Inc. and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Prescription Analgesics segment, which is expected to reach US$43.8 Billion by 2030 with a CAGR of a 5.0%. The OTC Analgesics segment is also set to grow at 5.8% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $17.2 Billion in 2024, and China, forecasted to grow at an impressive 7.1% CAGR to reach $10.8 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Segments:

• Drug Type (Prescription, OTC)
• Drug Class (Opioids, NSAIDs, Other Drug Classes)
• Route of Administration (Oral, Parenteral, Topical, Transdermal, Rectal)

Key Attributes:

Key Topics Covered:

MARKET OVERVIEW

• Analgesics - Global Key Competitors Percentage Market Share in 2024 (E)
• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• A Prelude to Analgesics
• Analgesics: Perfect Therapeutic Options to Solve Mild to Crippling Pain
• Key Segments
• Opioid Analgesics
• Non-Opioid Analgesics
• NSAIDs
• Topical NSAIDs
• Others
• Acetaminophen
• Adjuvant Analgesics
• Global Analgesics Market to Witness Rapid Growth
• Drugs Indicated for Pain Management
• The US and Europe Represent the Largest Regions, Asia-Pacific to Witness fastest Growth
• Non-Opioids: Fastest Growing Category
• Competition
• Recent Market Activity

MARKET TRENDS & DRIVERS

• Growing Aging Population & Increasing Burden of Chronic Diseases Spurs
• Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
• Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
• Rising Diabetes Prevalence Presents Opportunity for Cell Surface Markers: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
• Growing Incidence of Cancer and the Associated Pain to Drive the Analgesics Market
• Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
• Advancements in Design and Delivery of Analgesic Drugs
• Development of Safer Opioids with More Safer Profiles
• Drug Pipeline with Efficacious Drugs
• OTC Analgesics Market to Witness Fastest Growth
• Topical Analgesics Market Holds Significant Share
• Combination Therapies Gain Prominence
• A Few Novel Analgesic Products under Development
• E-commerce Platforms Strengthen Pharmaceutical Distribution in Crisis Period
• Neuropathic Pain Management: Market with High Potential
• Migraine Market: A Core Vertical in CNS Pain Management
• Reyvow, Eli Lilly's Novel Migraine Drug with the Potential to Lead the Global Migraine Medications Market
• Three New Migraine Drugs Obtain FDA Approval
• Eli Lilly's Emgality Receives FDA Approval
• Increasing Cases of Peripheral Nerve Injuries Drive the Analgesics Market

FOCUS ON SELECT PLAYERS: Some of the 146 major companies featured in this report

• Bristol-Myers Squibb Company
• Bayer AG
• Biological E. Ltd.
• Anabolic Laboratories LLC
• BioDelivery Sciences International, Inc.
• Brawn Laboratories Ltd.
• Angelini Holding S.p.A.
• AFT Pharmaceuticals Limited
• APT Asia Pacific
• Church & Dwight (Australia) Pty Ltd.
• Alliance Design and Development Group, Inc.
• Active Releaf Wellness Inc.
• Abiogen Pharma S.p.A.
• B-New Limited
• Celgene Corporation

For more information about this report visit https://www.researchandmarkets.com/r/endflm

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250224917921/en/